Thus, CARM1 may play a role in ovarian cancer progression in collaboration with NAC1, and high expression levels of NAC1 and CARM1 may serve as an informative prognostic biomarker for predicting resistance to chemotherapy for ovarian cancer. The gene discussed is CARM1; the disease is ovarian cancer.